Trials / Unknown
UnknownNCT00927771
Azelaic Acid Versus Hydroquinone in Melasma
Efficacy & Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Callender Center for Clinical Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to Hydroquinone Cream in the treatment of melasma.
Detailed description
Melasma is a chronic condition in which dark areas appear on the forehead, cheeks, and upper lips. Hydroquinone is a skin lightener (or fade cream) and is one of the most commonly used medications for the treatment of melasma. Azelaic acid gel is currently used to treat acne and rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azelaic acid gel | azelaic acid 15% gel twice a day for 6 months |
| DRUG | hydroquinone cream | hydroquinone 4% cream twice a day for 6 months |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-06-01
- Completion
- 2010-12-01
- First posted
- 2009-06-25
- Last updated
- 2009-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00927771. Inclusion in this directory is not an endorsement.